Endocyte Inc. (ECYT) Proves Why We Don’t Avoid 52-Week Lows

Oftentimes, investors are advised to ignore stocks making new lows. We’re told: “Never buy a stock hitting a 52-week low…” “Stocks in downtrends tend to stay in downtrends…” “It’s too risky… It’s not safe…” “Any stock hitting a 52-week low will always be weak…” Or, “nothing is more destructive to amateur investors than thinking that…